ebomi
Colour theme
Sign in
Insider · CIK 0001372932

DP VII Associates LP

CIK 0001372932 Name as filed on the most recent filing

Filed as DP VII Associates LP (42)

69 transaction lines · from 42 filings · filed 2008-12-11 to 2016-05-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-05-26 S, Open-market sale Evoke Pharma IncEVOK 27,636, disposed Open Form 4 filing 0000904454-16-001237
2016-04-27 S, Open-market sale Evoke Pharma IncEVOK 306, disposed Open Form 4 filing 0000904454-16-001190
2016-04-25 S, Open-market sale Evoke Pharma IncEVOK 109, disposed Open Form 4 filing 0000904454-16-001190
2016-04-20 S, Open-market sale Evoke Pharma IncEVOK 402, disposed Open Form 4 filing 0000904454-16-001172
2016-04-19 S, Open-market sale Evoke Pharma IncEVOK 3,388, disposed Open Form 4 filing 0000904454-16-001172
2016-04-11 S, Open-market sale Evoke Pharma IncEVOK 392, disposed Open Form 4 filing 0000904454-16-001166
2016-04-08 S, Open-market sale Evoke Pharma IncEVOK 1,343, disposed Open Form 4 filing 0000904454-16-001156
2016-04-07 S, Open-market sale Evoke Pharma IncEVOK 2,499, disposed Open Form 4 filing 0000904454-16-001156
2016-04-06 S, Open-market sale Evoke Pharma IncEVOK 773, disposed Open Form 4 filing 0000904454-16-001156
2015-08-18 S, Open-market sale Evoke Pharma IncEVOK 1,418, disposed Open Form 4 filing 0000904454-15-000538
2015-04-16 S, Open-market sale Evoke Pharma IncEVOK 3,917, disposed Open Form 4 filing 0000904454-15-000244
2015-04-15 S, Open-market sale Evoke Pharma IncEVOK 1,023, disposed Open Form 4 filing 0000904454-15-000244
2015-04-14 S, Open-market sale Evoke Pharma IncEVOK 1,307, disposed Open Form 4 filing 0000904454-15-000244
2013-07-01 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 67,074, acquired Open Form 4 filing 0000904454-13-000770
2013-06-04 S, Open-market sale Clovis Oncology, Inc.CLVS 179,468, disposed Open Form 4 filing 0000904454-13-000663
2013-03-21 S, Open-market sale Cadence Pharmaceuticals IncCADX 4,903, disposed Open Form 4 filing 0000904454-13-000467
2013-03-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 480, disposed Open Form 4 filing 0000904454-13-000459
2013-03-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 695, disposed Open Form 4 filing 0000904454-13-000459
2013-03-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 697, disposed Open Form 4 filing 0000904454-13-000449
2013-03-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 861, disposed Open Form 4 filing 0000904454-13-000449
2013-03-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 456, disposed Open Form 4 filing 0000904454-13-000439
2013-03-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 707, disposed Open Form 4 filing 0000904454-13-000439
2013-03-12 S, Open-market sale Cadence Pharmaceuticals IncCADX 576, disposed Open Form 4 filing 0000904454-13-000431
2013-03-11 S, Open-market sale Cadence Pharmaceuticals IncCADX 374, disposed Open Form 4 filing 0000904454-13-000431
2013-03-08 S, Open-market sale Cadence Pharmaceuticals IncCADX 468, disposed Open Form 4 filing 0000904454-13-000403
2013-03-07 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,122, disposed Open Form 4 filing 0000904454-13-000403
2013-03-06 S, Open-market sale Cadence Pharmaceuticals IncCADX 329, disposed Open Form 4 filing 0000904454-13-000391
2013-03-06 S, Open-market sale Clovis Oncology, Inc.CLVS 40,466, disposed Open Form 4 filing 0000904454-13-000386
2013-03-05 S, Open-market sale Cadence Pharmaceuticals IncCADX 346, disposed Open Form 4 filing 0000904454-13-000391
2013-03-05 S, Open-market sale Clovis Oncology, Inc.CLVS 52,639, disposed Open Form 4 filing 0000904454-13-000386
2013-03-04 S, Open-market sale Cadence Pharmaceuticals IncCADX 441, disposed Open Form 4 filing 0000904454-13-000380
2013-03-04 S, Open-market sale Clovis Oncology, Inc.CLVS 10,191, disposed Open Form 4 filing 0000904454-13-000386
2013-03-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 651, disposed Open Form 4 filing 0000904454-13-000380
2013-02-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 170, disposed Open Form 4 filing 0000904454-13-000319
2013-02-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 858, disposed Open Form 4 filing 0000904454-13-000313
2013-02-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 255, disposed Open Form 4 filing 0000904454-13-000313
2013-02-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 256, disposed Open Form 4 filing 0000904454-13-000299
2013-02-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 490, disposed Open Form 4 filing 0000904454-13-000299
2013-02-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 795, disposed Open Form 4 filing 0000904454-13-000163
2013-01-31 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,479, disposed Open Form 4 filing 0000904454-13-000146
2013-01-30 S, Open-market sale Cadence Pharmaceuticals IncCADX 940, disposed Open Form 4 filing 0000904454-13-000146
2013-01-29 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,370, disposed Open Form 4 filing 0000904454-13-000138
2013-01-28 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,523, disposed Open Form 4 filing 0000904454-13-000138
2013-01-25 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,259, disposed Open Form 4 filing 0000904454-13-000128
2013-01-24 S, Open-market sale Cadence Pharmaceuticals IncCADX 3,357, disposed Open Form 4 filing 0000904454-13-000128
2013-01-23 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,197, disposed Open Form 4 filing 0000904454-13-000082
2013-01-22 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,275, disposed Open Form 4 filing 0000904454-13-000082
2013-01-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,682, disposed Open Form 4 filing 0000904454-13-000062
2013-01-17 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,145, disposed Open Form 4 filing 0000904454-13-000062
2011-12-22 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 11,429, acquired Open Form 4 filing 0000904454-11-000679

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DP VII ASSOCIATES LP, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001372932

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.